For example, activated FAK/Syk/Akt/mTOR and STAT3 pathways are known to underlie Reelin-driven cancer cell growth and metabolic reprogramming, including glycolysis in myeloma cells [23]. The gene discussed is STAT3; the disease is plasma cell myeloma.